Clinical Trial

The Pancreatic Enzymes After Gastrectomy Trial

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This trial evaluates the effects (e.g. on quality of life, weight) of NORTASE® compared to standard care of patients who have undergone gastrectomy.
Protocol Amendment History 3 changes
notable Trial sites expanded: 9 -> 12 locations 2026-08-13
notable Primary completion pushed: 2027-06 -> 2028-02 2026-08-13
minor Completion pushed: 2027-06 -> 2028-02 2026-08-13
Trial Details
NCT Number NCT06058442
Lead Sponsor University of Leipzig
Conditions Gastrectomy
Enrollment 188 participants
Start Date 2024-01-24
Primary Completion 2028-02 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2026-08-12